AYTU BIOPHARMA, INC Finance Lease, Right-of-Use Asset, after Accumulated Amortization
AYTU BIOPHARMA, INC (AYTU) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $0 as of 2024-06-30, per its 10-K filed 2024-09-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2024-09-26
- 2024-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2024-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2023-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $159.00K.
- 2023-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $174.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2024-06-30 | $0.00 10-K · filed 2024-09-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 |
| 2023-06-30 | $159.00K 10-K · filed 2024-09-26 |
| 2023-03-31 | $174.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $188.00K 10-Q · filed 2023-02-21 |
| 2022-09-30 | $238.00K 10-Q/A · filed 2023-02-21 |
| 2022-06-30 | $256.00K 10-K · filed 2023-10-12 |
| 2022-03-31 | $274.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $292.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $311.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $329.00K 10-K · filed 2022-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |